Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Unexpected activity of oral fosfomycin against resistant strains of Escherichia coli in murine pyelonephritis.

Pourbaix A, Guérin F, Burdet C, Massias L, Chau F, Cattoir V, Fantin B.

Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00903-19. doi: 10.1128/AAC.00903-19. [Epub ahead of print]

PMID:
31160291
2.

HIV infection in North African patients.

Parisey M, Louni F, Bouvet E, Landman R, Charpentier C, Lariven S, Joly V, Villemant A, Mackoumbou-Nkouka C, Yazdanpanah Y, Burdet C.

AIDS Res Hum Retroviruses. 2019 May 17. doi: 10.1089/AID.2018.0292. [Epub ahead of print]

PMID:
31099259
3.

Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.

Burdet C, Grall N, Linard M, Bridier-Nahmias A, Benhayoun M, Bourabha K, Magnan M, Clermont O, d'Humières C, Tenaillon O, Denamur E, Massias L, Tubiana S, Alavoine L, Andremont A, Mentré F, Duval X; CEREMI Group.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02244-18. doi: 10.1128/AAC.02244-18. Print 2019 Jun.

PMID:
30936104
4.

Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL).

Joly V, Burdet C, Landman R, Vigan M, Charpentier C, Katlama C, Cabié A, Benalycherif A, Peytavin G, Yeni P, Mentre F, Argoud AL, Amri I, Descamps D, Yazdanpanah Y; LAMIDOL Study Group.

J Antimicrob Chemother. 2019 Mar 1;74(3):739-745. doi: 10.1093/jac/dky467.

PMID:
30476165
5.

Carbapenems and alternative β-lactams for the treatment of infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae: What impact on intestinal colonisation resistance?

Woerther PL, Lepeule R, Burdet C, Decousser JW, Ruppé É, Barbier F.

Int J Antimicrob Agents. 2018 Dec;52(6):762-770. doi: 10.1016/j.ijantimicag.2018.08.026. Epub 2018 Aug 31. Review.

PMID:
30176355
6.

Efficacy of cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial.

Burdet C, Loubet P, Le Moing V, Vindrios W, Esposito-Farèse M, Linard M, Ferry T, Massias L, Tattevin P, Wolff M, Vandenesch F, Grall N, Quintin C, Mentré F, Duval X, Lescure FX; CloCeBa study group.

BMJ Open. 2018 Sep 1;8(8):e023151. doi: 10.1136/bmjopen-2018-023151.

7.

Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection.

Burdet C, Sayah-Jeanne S, Nguyen TT, Hugon P, Sablier-Gallis F, Saint-Lu N, Corbel T, Ferreira S, Pulse M, Weiss W, Andremont A, Mentré F, de Gunzburg J.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e00925-18. doi: 10.1128/AAC.00925-18. Print 2018 Oct.

8.

Need for integrative thinking to fight against emerging infectious diseases. Proceedings of the 5th seminar on emerging infectious diseases, March 22, 2016 - current trends and proposals.

Burdet C, Guégan JF, Duval X, Le Tyrant M, Bergeron H, Manuguerra JC, Raude J, Leport C, Zylberman P.

Rev Epidemiol Sante Publique. 2018 Feb;66(1):81-90. doi: 10.1016/j.respe.2017.08.001. Epub 2017 Dec 6.

9.

Protection of the Human Gut Microbiome From Antibiotics.

de Gunzburg J, Ghozlane A, Ducher A, Le Chatelier E, Duval X, Ruppé E, Armand-Lefevre L, Sablier-Gallis F, Burdet C, Alavoine L, Chachaty E, Augustin V, Varastet M, Levenez F, Kennedy S, Pons N, Mentré F, Andremont A.

J Infect Dis. 2018 Jan 30;217(4):628-636. doi: 10.1093/infdis/jix604.

10.

Impact of antibiotics on the intestinal microbiota needs to be re-defined to optimize antibiotic usage.

Ruppé E, Burdet C, Grall N, de Lastours V, Lescure FX, Andremont A, Armand-Lefèvre L.

Clin Microbiol Infect. 2018 Jan;24(1):3-5. doi: 10.1016/j.cmi.2017.09.017. Epub 2017 Sep 29. No abstract available.

11.

Protection of Hamsters from Mortality by Reducing Fecal Moxifloxacin Concentration with DAV131A in a Model of Moxifloxacin-Induced Clostridium difficile Colitis.

Burdet C, Sayah-Jeanne S, Nguyen TT, Miossec C, Saint-Lu N, Pulse M, Weiss W, Andremont A, Mentré F, de Gunzburg J.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00543-17. doi: 10.1128/AAC.00543-17. Print 2017 Oct.

12.

Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016.

Visseaux B, Burdet C, Voiriot G, Lescure FX, Chougar T, Brugière O, Crestani B, Casalino E, Charpentier C, Descamps D, Timsit JF, Yazdanpanah Y, Houhou-Fidouh N.

PLoS One. 2017 Jul 14;12(7):e0180888. doi: 10.1371/journal.pone.0180888. eCollection 2017.

13.

Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review.

Loubet P, Burdet C, Vindrios W, Grall N, Wolff M, Yazdanpanah Y, Andremont A, Duval X, Lescure FX.

Clin Microbiol Infect. 2018 Feb;24(2):125-132. doi: 10.1016/j.cmi.2017.07.003. Epub 2017 Jul 8. Review.

14.

Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia.

Voiriot G, Visseaux B, Cohen J, Nguyen LB, Neuville M, Morbieu C, Burdet C, Radjou A, Lescure FX, Smonig R, Armand-Lefèvre L, Mourvillier B, Yazdanpanah Y, Soubirou JF, Ruckly S, Houhou-Fidouh N, Timsit JF.

Crit Care. 2016 Oct 25;20(1):375.

15.

Intestinal carriage of Extended Spectrum Beta-Lactamase producing E. coli in women with urinary tract infections, Cameroon.

Djuikoue IC, Woerther PL, Toukam M, Burdet C, Ruppé E, Gonsu KH, Fokunang C, El Mniai A, Larissa K, Pieme AC, Mboupaing MG, Kakam CM, Fogang HK, Andremont A, Ngogang J.

J Infect Dev Ctries. 2016 Oct 31;10(10):1135-1139. doi: 10.3855/jidc.7616.

16.

18FDG-PET/CT: a useful tool for the management of patients in infectious diseases.

Pichon M, Mikail N, Ben Ali K, Rouzet F, Burdet C, Yazdanpanah Y, Joly V, Lepage L, Sarda-Mantel L.

Infect Dis (Lond). 2017 Feb;49(2):155-157. Epub 2016 Sep 12. No abstract available.

PMID:
27619910
17.

Prospective Cohort Study of the Relative Abundance of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli in the Gut of Patients Admitted to Hospitals.

de Lastours V, Chopin D, Jacquier H, d'Humières C, Burdet C, Chau F, Denamur E, Fantin B.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6941-6944. doi: 10.1128/AAC.01328-16. Print 2016 Nov.

18.

Epidemiological Profile of Newly Diagnosed HIV-Infected Patients in Northern Paris: A Retrospective Study.

Senard O, Burdet C, Visseaux B, Charpentier C, Le Gac S, Julia Z, Lariven S, Descamps D, Yazdanpanah Y, Yeni P, Joly V.

AIDS Res Hum Retroviruses. 2017 Jan;33(1):11-16. doi: 10.1089/AID.2016.0036. Epub 2016 Sep 7.

PMID:
27476681
19.

Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.

Pommier JD, Ben Lasfar N, Van Grunderbeeck N, Burdet C, Laouénan C, Rioux C, Pierre-Audigier C, Meybeck A, Choudat L, Benchikh A, Nguyen S, Bouvet E, Yeni P, Yazdanpanah Y, Joly V.

Infect Dis (Lond). 2015;47(10):725-31. doi: 10.3109/23744235.2015.1055794. Epub 2015 Jun 16.

PMID:
26077036
20.

[Effective prevention of pneumococcal infections in adults aged 65 and over].

Burdet CE.

Rev Med Suisse. 2015 Apr 15;11(470):889. French. No abstract available.

PMID:
26050312
21.

Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia.

Pajot O, Burdet C, Couffignal C, Massias L, Armand-Lefevre L, Foucrier A, Da Silva D, Lasocki S, Laouénan C, Mentec H, Mentré F, Wolff M.

J Antimicrob Chemother. 2015 May;70(5):1487-94. doi: 10.1093/jac/dku569. Epub 2015 Jan 27.

PMID:
25630642
22.

[An update on measles].

Caseris M, Burdet C, Lepeule R, Houhou N, Yeni P, Yazdanpanah Y, Joly V.

Rev Med Interne. 2015 May;36(5):339-45. doi: 10.1016/j.revmed.2014.10.362. Epub 2015 Jan 8. Review. French.

PMID:
25579464
23.

Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia.

Burdet C, Pajot O, Couffignal C, Armand-Lefèvre L, Foucrier A, Laouénan C, Wolff M, Massias L, Mentré F.

Eur J Clin Pharmacol. 2015 Jan;71(1):75-83. doi: 10.1007/s00228-014-1766-y. Epub 2014 Oct 21.

24.

Escherichia coli bacteremia in children: age and portal of entry are the main predictors of severity.

Burdet C, Clermont O, Bonacorsi S, Laouénan C, Bingen E, Aujard Y, Mentré F, Lefort A, Denamur E; COLIBAFI Group.

Pediatr Infect Dis J. 2014 Aug;33(8):872-9. doi: 10.1097/INF.0000000000000309.

PMID:
25222308
25.

Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses.

Surgers L, Bleibtreu A, Burdet C, Clermont O, Laouénan C, Lefort A, Mentré F, Carbonne B, Bingen E, Meynard JL, Denamur E; COLIBAFI Group.

Clin Microbiol Infect. 2014 Dec;20(12):O1035-41. doi: 10.1111/1469-0691.12742. Epub 2014 Aug 11.

26.

Population pharmacokinetics of imipenem in critically ill patients with suspected ventilator-associated pneumonia and evaluation of dosage regimens.

Couffignal C, Pajot O, Laouénan C, Burdet C, Foucrier A, Wolff M, Armand-Lefevre L, Mentré F, Massias L.

Br J Clin Pharmacol. 2014 Nov;78(5):1022-34. doi: 10.1111/bcp.12435.

27.

Quinolones versus macrolides in the treatment of legionellosis: a systematic review and meta-analysis.

Burdet C, Lepeule R, Duval X, Caseris M, Rioux C, Lucet JC, Yazdanpanah Y.

J Antimicrob Chemother. 2014 Sep;69(9):2354-60. doi: 10.1093/jac/dku159. Epub 2014 May 14. Review.

PMID:
24827889
28.

Predictors of return rate for an HIV-positive result in a French Voluntary Counseling and Testing centre.

Pahlavan G, Burdet C, Laouénan C, Guiroy F, Bouscarat F, Tosini W, Yazdanpanah Y, Bouvet E.

Int J STD AIDS. 2015 Jan;26(1):33-6. doi: 10.1177/0956462414528884. Epub 2014 Apr 2.

PMID:
24695014
29.

Quinolone-resistant Escherichia coli from the faecal microbiota of healthy volunteers after ciprofloxacin exposure are highly adapted to a commensal lifestyle.

de Lastours V, Bleibtreu A, Chau F, Burdet C, Duval X, Denamur E, Fantin B.

J Antimicrob Chemother. 2014 Mar;69(3):761-8. doi: 10.1093/jac/dkt422. Epub 2013 Oct 22.

PMID:
24150843
30.

Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Woerther PL, Burdet C, Chachaty E, Andremont A.

Clin Microbiol Rev. 2013 Oct;26(4):744-58. doi: 10.1128/CMR.00023-13. Review.

31.

Complexity of Escherichia coli bacteremia pathophysiology evidenced by comparison of isolates from blood and portal of entry within single patients.

Clermont O, Glodt J, Burdet C, Pognard D, Lefort A, Branger C, Denamur E; COLIBAFI Group Members.

Int J Med Microbiol. 2013 Dec;303(8):529-32. doi: 10.1016/j.ijmm.2013.07.002. Epub 2013 Jul 17.

PMID:
23927963
32.

Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation.

Wyplosz B, Burdet C, François H, Durrbach A, Duclos-Vallée JC, Mamzer-Bruneel MF, Poujol P, Launay O, Samuel D, Vittecoq D, Consigny PH; GEVACCIM.

Am J Transplant. 2013 Sep;13(9):2458-61. doi: 10.1111/ajt.12338. Epub 2013 Jul 8.

33.

How performing a repetitive one-legged stance modifies two-legged postural control.

Burdet C, Vuillerme N, Rougier PR.

J Strength Cond Res. 2011 Oct;25(10):2911-8. doi: 10.1519/JSC.0b013e31820f6ef5.

PMID:
21912279
34.
35.
36.
37.

Recalibration of somesthetic plantar information in the control of undisturbed upright stance maintenance.

Bernard-Demanze L, Burdet C, Berger L, Rougier P.

J Integr Neurosci. 2004 Dec;3(4):433-51.

PMID:
15657978
38.

How postural behaviour in undisturbed upright stance can be used to assess the physical characteristics of various models of ankle orthoses.

Rougier P, Burdet C, Farenc I, Berger L.

Clin Biomech (Bristol, Avon). 2004 Jun;19(5):497-505.

PMID:
15182985
39.

Backward and forward leaning postures modelled by an fBm framework.

Rougier P, Burdet C, Farenc I, Berger L.

Neurosci Res. 2001 Sep;41(1):41-50.

PMID:
11535292
41.

Lymphoproliferative disorders in IL-7 transgenic mice: expansion of immature B cells which retain macrophage potential.

Fisher AG, Burdet C, Bunce C, Merkenschlager M, Ceredig R.

Int Immunol. 1995 Mar;7(3):415-23.

PMID:
7794821
42.
43.
44.

Lymphoproliferative disorders in an IL-7 transgenic mouse line.

Fisher AG, Burdet C, LeMeur M, Haasner D, Gerber P, Ceredig R.

Leukemia. 1993 Aug;7 Suppl 2:S66-8.

PMID:
8361236
45.

T cell receptor repertoire of gamma delta cells generated from the 14-day embryonic mouse thymus.

Schleussner C, Kuzio S, Schultze N, Burdet C, Fisher AG, Ceredig R.

Thymus. 1992 Dec;20(4):195-216.

PMID:
1492360

Supplemental Content

Loading ...
Support Center